On Track To Approval, Alkermes Hopes ALKS-5461 Can Change Future Of Depression Therapy

The novel opioid-system antidepressant is being positioned for adjunctive therapy on top of SSRIs, but Alkermes is eyeing other indications, and better ways to stratify and treat depressed patients.